Brilliant Stain Buffer Plus

The BD Horizon Brilliant Stain Buffer Plus is a buffer formulated for the immunofluorescent staining of cells. This buffer was developed to have a reduced test volume for applications where total staining volume is a concern. Brilliant Stain Buffer Plus is as effective as BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) in mitigating staining artifacts seen when using multiple BD Horizon Brilliant reagents. For optimal and reproducible results, either BD Horizon Brilliant Stain Buffer Plus or BD Horizon Brilliant Stain Buffer should be used anytime BD Horizon Brilliant™ dye-conjugated reagents are used. The BD Horizon Brilliant Stain Buffer Plus is compatible with the use of other fluorescent staining reagents conjugated with traditional fluorochromes, such as fluorescein, phycoerythrin or Alexa Fluor® dyes.

The BD Horizon Brilliant Stain Buffer Plus is a buffer formulated for the immunofluorescent staining of cells. This buffer was developed to have a reduced test volume for applications where total staining volume is a concern. Brilliant Stain Buffer Plus is as effective as BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) in mitigating staining artifacts seen when using multiple BD Horizon Brilliant reagents. For optimal and reproducible results, either BD Horizon Brilliant Stain Buffer Plus or BD Horizon Brilliant Stain Buffer should be used anytime BD Horizon Brilliant™ dye-conjugated reagents are used. The BD Horizon Brilliant Stain Buffer Plus is compatible with the use of other fluorescent staining reagents conjugated with traditional fluorochromes, such as fluorescein, phycoerythrin or Alexa Fluor® dyes.

Flow cytometry (Tested During Development)

Aqueous buffered solution containing BSA and ≤0.09% sodium azide.

Development References(7) 1. Acosta JR, Douagi I, Andersson DP, et al. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes.. Diabetologia. 2016; 59(3):560-70. (Methodology: Flow cytometry). 2. Andrés-Blasco I, Herrero-Cervera A, Vinué Á, et al. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.. J Endocrinol. 2015; 227(3):179-91. (Methodology: Flow cytometry). 3. Ingelman-Sundberg HM, Laestadius Å, Chrapkowska C, et al. Diverse effects on vaccine-specific serum IgG titres and memory B cells upon methotrexate and anti-TNF-α therapy in children with rheumatic diseases: A cross-sectional study.. Vaccine. 2016; 34(10):1304-11. (Methodology: Flow cytometry). 4. Leijten EF, van Kempen TS, Boes M, et al. Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid.. 2015; 67(10):2673-8. (Methodology: Flow cytometry). 5. McKay FC, Gatt PN, Fewings N, et al. The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.. Clin Immunol. 2016; 163:96-107. (Methodology: Flow cytometry). 6. O'Connor KS, Read SA, Wang M, et al. IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection.. Genes Immun. 2016; 17(6):328-34. (Methodology: Flow cytometry). 7. Vinué Á, Andrés-Blasco I, Herrero-Cervera A, et al. Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling.. Biochim Biophys Acta. 2015; 1852(9):1729-42. (Methodology: Flow cytometry).